The funding from foundation-owned DNV will support single patient record functionality and global expansion.
"We are thrilled to welcome DNV as a true partner. This is a strategic alignment with a Foundation that believes in our mission and with which we share great synergies. DNV’s global reach, well-connected network, and ethical alignment with our status as a social enterprise are exactly what we were looking for in a partner. I’m also extremely grateful to the team at FirstCapital, led by Co-Founder and Chairman Hazel Moore, for advising us on this transaction – their support has been invaluable."
The Series A round was led by Notion Capital with participation from multiple venture firms and angel investors.
"Every Trust we meet tells us the same story: they need qualified staff now, but they cannot risk patient safety or compliance. Our platform gives them speed without compromise, predictability without cost inflation, and sustainability where locum dependency has become unsustainable. TERN Group’s mission is for every placement to set off a chain reaction: anurse arriving on time means a ward runs smoothly, which means patients get treated faster. This raise enables us to make those chain reactions happen at scale, across the UK and beyond."
The pre-seed round was backed by RAW Ventures and Cedars-Sinai Ventures to fund clinical deployment and regulatory approvals.
"We’re focused on leveraging the unique capabilities of ultrasound and developing solutions to make it smarter, faster, and more reliable, with clinicians at the centre of that transformation. This trial will assess the effectiveness of FraiyaScan in real world conditions. Importantly, the frontline staff and patient feedback will help us to understand the acceptability of the technology, where time-pressured scans, staffing gaps, and service variability, that can affect outcomes, may also impact the performance and adoption of AI-based innovations."
— Jackie Matthew, chief medical officer and clinical academic sonographer
The investment was led by Foresight Group to support the company in scaling its digital healthcare solutions.
"We are delighted to have secured investment from Foresight, marking a significant milestone in MWDH’s journey. Their support will enable us to accelerate our growth strategy, broaden our product offering, and further expand our global footprint."
Investing Women Angels backed the pre-seed round to support product development and market entry.
"At Petscribers, everything we do is rooted in our experience as practising vets. We’re building the tools and support we wish we’d had in practice, to make pet healthcare clearer, simpler, and more affordable For us, investment has never just been about money. We’ve been intentional about finding investors who share our purpose, believe in our vision, and genuinely care about improving access to veterinary care. We’re proud to have an incredible group of individuals behind us. People who understand the change we’re working towards and are with us every step of the way."
